Consistent with our findings that CACT expression was downregulated in CMTs, another previous study confirmed that in human bladder cancer patients, the expression of CACT was significantly deregulated in cancer tissues compared with healthy bladder tissues [33]. This evidence concerns the gene SLC25A20 and cancer.